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1. INTRODUCTION 
Blood is a biological fluid that circulates throughout the body 
and contains extensive information on the state of a person’s 
health and disease. It is composed of a conductive liquid (plasma) 
and a suspension of particles (red blood cells, white blood cells, 
and platelets). Once blood coagulates, cells aggregate to form red 
clots, and the surrounding liquid becomes serum. When making 
decisions about diagnoses, necessary further investigations, or 
patient management, clinicians rely on the results of blood 
laboratory analyses. It is, thus, clearly necessary to ensure the 
reliability and the accuracy of these analyses in healthcare to 
guarantee that the laboratory tests accurately reflect the patient’s 
health state. 
A huge number of control systems have been developed and 
used in most clinical laboratories to maintain high quality in the 
analytical phase [1]. This is not the case for the pre-analytical 
phase. The majority of laboratory errors are made in this phase, 
which covers all processes from the time that a laboratory test 
request is made by a physician until the sample is ready for 
testing. The magnitude of the effect of these errors on patient 
care is significant, and the focus of healthcare institutions is the 
improvement of laboratory test quality, renewing the interest in 
pre-analytical processes. Thus, the use of quality controls to 
prevent laboratory errors should be an essential activity for any 
healthcare laboratory [2]-[5]. Unfortunately, despite that several 
methods and systems are currently used in clinics for the 
preparation of quality control samples [6], [7], in practice, they 
depend on high dimensions instrumentation and specific 
commercial kits, whose usage procedures require optimization. 
The most frequent reason for the inadequacy of a sample, 
such sample being able to cause analytical errors in laboratories, 
is represented by hemolysis (i.e., the rupture of red blood cells), 
giving rise to the release of intracellular content, such as 
ABSTRACT 
In clinical laboratories, the major proportion of errors regarding blood analyses occurs in the pre-analytical phase. Pre-analytical 
conditions are key, necessary factors in maintaining the high quality of specimens, limiting day-to-day and batch variations, and 
guaranteeing the absolute reliability and accuracy of clinical results and related diagnoses. The quality of serum samples must be very 
high in order to avoid interferences due to hemolysis, thereby preventing measurement errors. In addition, the quality of the blood 
should always be fast monitored to identify inadequacies and guarantee their complete usability in transfusion procedures. In the near 
future, the solution could be to supply laboratories with smart and portable devices that are able to perform fast quality tests for every 
sample. Electrical impedance has relevant potential in analyzing and monitoring blood quality. We propose a new, simple impedance-
based biosensor that can perform accurate and efficient single and multi-frequency impedance measurements in the pre-analytical 
phase and to check the quality of blood samples using quantitative thresholds as useful indicators to ensure the reliability of results and 
thereby prevent laboratory errors. The proposed sensor allows for discriminating different blood components, identifying hemolysis in 
serum, evaluating blood quality, and rapidly quantifying its hematocrit.  
 ACTA IMEKO | www.imeko.org December 2018 | Volume 7 | Number 4 | 27 
 
hemoglobin. Free hemoglobin causes interferences in many 
dosage methods and colorimetric analysis and makes serum 
samples unsuitable for analysis. Another inadequacy in a sample 
is that the serum contains minute white clots, i.e., clots without 
red cells that are made by a structural net (called fibrin) that 
forms during coagulation. Limited presence of hemolysis or 
white clots is a sufficient basis for technical problems and 
measurement disruption [8], [9]. Nevertheless, the quality of 
serum in the pre-analytical phase is usually measured only for 
samples that visibly show pale red hemolytic shades, while it 
should be rapidly and always tested for every sample, without 
exclusion, in order to assure the complete accuracy of laboratory 
analyses.  
In addition, quality control of every sample before laboratory 
analysis or transfusion is not always provided for blood that is 
collected from both healthy donors and patients. Consequently, 
the identification of inadequacies and the prevention of 
measurement errors are not guaranteed. Anomalies involving the 
temperature of the containers for the transport and storage of 
blood are frequent and common and can lead to variations in 
blood consistency and to its undesired coagulation. These 
problems should be identified and monitored by means of 
auxiliary investigations to adequately preserve the samples and to 
rapidly identify the opportune corrective actions. Accordingly, 
changes in hematocrit value, i.e., the volume of red blood cells as 
a percentage of the whole blood volume, could represent a useful 
indicator of transport and storage conditions quality. Thus, the 
quality of blood samples should be always quantified quickly to 
guarantee their complete compatibility and efficiency in 
transfusion procedures and to avoid anomalies and errors in 
laboratory analyses. 
Electrical measurements represent a highly promising tool for 
analyzing blood. The relevance of the impedance measurement 
technique for characterizing biomedical human aspects has 
already been proposed in [10], [11]. Blood consists of conductive 
plasma and suspended cells (especially red blood cells, but also 
white cells and platelets). Cells are composed of an outer lipidic 
capacitive membrane, which contains an intracellular fluid with 
dielectric and resistive properties that are similar to plasma. 
Damage to the membrane and, consequently, to its functions is 
lethal for the cell. Ordinary circuit elements, such as resistors and 
capacitors, are considered as lumped-constant quantities, which 
have ideal properties. With the aim of modeling blood in terms 
of its components and dynamic behavior, ideal circuit elements 
may be inadequate in describing its electrical response. In 
addition, the interaction of blood with electrodes is too complex 
to be represented with the ideal response expected for a single 
electrochemical reaction. The interaction between a biological 
fluid and a metal electrode forms a narrow interface, known as a 
double layer, where the current flows as in a capacitive layer, but 
the current phase shift, in magnitude, is less than -90°. Both the 
blood and the double layer are thus modeled using the Constant 
Phase Element (CPE) [12] in the equivalent circuit. The CPE is 
considered a distributed impedance element, examining the 
imperfect responses of real systems whose impedance is defined 
as ŻCPE(ω) = 1/[CCPE(jω)ψ] [12]. The parameter ψ, with 0 ≤ ψ ≤ 
1, is the phase shift or phase angle, while CCPE is the capacitance. 
When ψ = 0 the CPE resembles a pure resistor, instead, when 
ψ = 1, the CPE looks like an ideal capacitor.  
Measurements for the characterization of whole blood 
dynamic behavior in artificial micro-channels have been 
presented using electrical impedance spectroscopy, as described 
in [13]-[17], by using an impedance meter and a low-cost sensor 
based on printed circuit board technology. With regard to the 
characterization of single blood components, this challenge is 
still open and has not yet been settled by a single multi-
measurement sensor. 
Here, we propose a new, simple, impedance-based sensing 
device. Comparing and combining the data on impedance 
measurements, we are able to characterize and discriminate 
different blood components and to perform fast and accurate 
controls to test the quality of blood and serum samples, with the 
possibility of confirming or rejecting their usability in clinics. 
2. MATERIALS AND METHODS 
For each experiment, 3 ml of venous blood was collected into 
citrate as anticoagulant (hematocrit of 38 ± 3 %) from each of 
the healthy blood donors who participated in this study. 
Informed written consent was obtained from the participants 
according to the Declaration of Helsinki and the DMS of the 
Italian Ministry of Health on November 2nd 2015 (concerning 
the quality and safety of blood and blood donors). The Ethics 
Committee CRO-IRCCS Aviano approved the study. 
Afterwards, each vial of whole blood was divided into three parts 
with the aim of obtaining the materials demonstrated in Figure 
1a. One part of the whole blood (1 ml) was left untreated (whole 
blood shown in Figure 1a). Another part of the whole blood 
(1 ml) was centrifuged to obtain, as shown in Figure 1b, plasma 
(a liquid substance with all the coagulation proteins, but without 
cells) and whole concentrated blood (red cells, white cells, and 
platelets, with a hematocrit of 60 ± 3 %). Finally, for the last 1 ml, 
CaCl2 (5 mM final concentration) was added to stimulate the 
coagulation process and to obtain serum (a liquid substance 
without cells and without coagulation proteins) and the red clot 
(red cells, white cells, platelets, and fibrin). The serum thus 
extracted can appear yellow (the serum in Figure 1a) or it can 
show pale red shades (the serum with low or high hemolysis in 
Figure 1a, c, and d), a visible indication of the presence of 
hemolysis due to damage to red blood cells. In addition, serum 
can sporadically contain fibrin white clots. If the serum expresses 
hemolysis, the white clot can contain fragments of damaged red 
blood cells, and it looks light red (the white clot with hemolysis 
in Figure 1a). These anomalous situations, not always identifiable 
by eye, can lead to technical problems and measurement 
interferences if they are not rapidly recognized. 
 
Figure 1. Blood components characterized with impedance measurements. 
Components disposed in plastic wells (a). Whole blood centrifuged (b). 
Blood coagulated and centrifuged (c, d). 
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Each blood component was homogeneously disposed in a 
single well (200 μl of substance, well diameter: 16 mm) and their 
electrical impedance was measured by using a low-cost, small, 
and reproducible sensing module with a simple geometry (Figure 
2a). The sensing module appears as a capacitor with parallel 
planar surfaces made of copper (width: 7 mm, distance between 
surfaces: 4 mm). A polycarbonate cap supports the accurate 
positioning of the capacitor in the blood substance (as 
schematically shown Figure 2a and Figure 2b) and, consequently, 
maintains the stability of the measurements. The device was 
connected to a high-precision LCR meter [18] in order to 
perform the impedance measurement in the frequency range 
[100 Hz, 2 MHz] with 20 logarithmic spaced steps. A drive 
voltage of 50 mV was chosen, considering the electrochemical 
properties of the materials, and open-short calibration was 
applied with the aim of reducing parasitic effects.  
The equivalent lumped circuit is presented in Figure 2c. It 
allowed for a satisfactory correlation between the experimental 
data and the physical processes that govern the system. The 
double layer at the interface is represented by CPE1, 
characterized by capacitance C1 and phase shift ψ1, whose 
impedance is ŻCPE1(ω) = 1/[C1(jω)ψ1]. Furthermore, according to 
the purely resistive behavior of the extracellular fluid and 
considering the necessity of representing different cellular and 
membrane conditions with a generalized and versatile circuit 
element, blood was modeled in terms of a parallel between the 
resistance and the CPE. The CPE2 models the cells with their 
membrane and is characterized by capacitance C2 and phase shift 
ψ2, and exhibits and impedance ŻCPE2(ω) = 1/[C2(jω)ψ2], while 
resistance R represents the fluid in which the cells are suspended. 
The blood of n = 20 different donors, equally distributed in 
terms of gender, was collected and analyzed, obtaining 
impedance signals varying with frequency and stable in time. In 
addition, the hematocrit was measured for all the blood samples 
with a commercial instrument that is commonly used in clinical 
laboratories.  
3. RESULTS AND DISCUSSIONS 
 Characterization of blood components  
Impedance signals related to the different blood components 
of Figure 1 are displayed in Figure 3 as magnitude (left panel) and 
phase (right panel). For each material, the average signal, with its 
related standard deviation, is illustrated (n = 20). It is evidently 
possible to use this new prototype to discriminate blood 
components on the basis of their impedance magnitude and 
phase, which are representative of their resistance to the current 
flow and depend on the amount of the capacitive contribution 
due to the lipidic membrane (mostly of the red blood cells). In 
particular, observing the magnitude of impedance at the central 
frequencies in Figure 3, from the bottom to the top, following a 
decrease of conductivity, we can observe in order: white clot, 
plasma, serum, white clot with hemolysis, serum with increasing 
levels of hemolysis, whole blood at different densities, and red 
clot. The properties of blood components, revealing that the 
electrical conductance decreases as the red blood cells 
concentration increases, can also be qualitatively appreciated 
from the phase diagrams of Figure 3, where it is evident that all 
the blood components without red cells or containing damaged 
 
Figure 2. Sensing module for electrical impedance measurements. A 
polycarbonate cap is placed on each well, and the parallel copper conductive 
surfaces are immersed in the fluid substance (a, b). Equivalent circuit (c). 
 
Figure 3. Electrical impedance signals displayed as magnitude (left panel) and phase (right panel). Each blood component is represented in terms of mean 
and standard deviation (n = 20). 
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red cells have an impedance phase that is distinguishable from 
the impedance phase of samples with healthy red blood cells. 
In addition to the evident capability of characterizing different 
blood components with electrical impedance measurements, the 
most promising results (presented in Figure 3) are shown by the 
curves of serum (pure or with hemolysis as well as those relative 
to the blood), specifically the combination that comprises whole 
blood, whole concentrated blood, and red clot. These results 
allow for associating and proposing a specific quantitative pre-
analytical threshold value for the rapid quality control of serum 
and whole blood samples. According to the impedance 
magnitude signals analyzed and shown here, we can thus confirm 
that serum and whole blood samples can be accepted for 
laboratory analyses and transfusions if their impedance 
magnitude levels at the central frequencies measured with our 
sensor do not exceed 700 Ω and 3 kΩ, respectively.  
An interesting point that deserves attention and further 
experiments is represented by the white clot curves. In Figure 3, 
white clots without hemolysis seem to be the most conductive 
material among those analyzed, which is because the fiber net is 
a highly conductive structure of fibrin, and there are no resistive 
cellular components inside. By using this approach, fibrin could 
be electrically described, and its formation could be identified 
and monitored in real time during the whole physiological 
process of coagulation.   
The discrimination of blood components through the 
impedance signals was confirmed and enriched by the inverse 
analysis performed using complex non-linear least square 
(CNLS) fitting software. Thanks to this software, it was possible 
to quantify each single lumped elements parameter introduced in 
Figure 2c (C1, ψ1, R, C2, ψ2) with an uncertainty in the order of 
2%. The numerical parameters estimated, related to the 
equivalent circuit of Figure 2c, are displayed in Table 1 and are 
expressed in terms of mean and standard deviation (n = 20). An 
important aspect of the electrical characterization of a system is 
the possibility to identify and associate equivalent circuit 
elements with specific physical processes occurring. In particular, 
the parameters of CPE1, related to the double layer, (C1, ψ1) 
appear to be almost equal among all the blood components 
analyzed. In fact, the double layer is common among all the 
blood components because it is associated with the interface 
interaction between the material and the metallic electrodes. For 
this reason, CPE1, representing a common electrical behavior, 
can be compensated with the aim of evidencing the specific 
electrical properties of each biological material, dealing with the 
specific electrical response of the material alone. The numerical 
results confirm that the CPE2 is directly related to the presence 
or the absence of cells (mostly red blood cells) and the possible 
breaking of their membrane. In particular, the values of the CPE2 
parameters (C2, ψ2) and R are significantly different if there are 
cells (the higher the number or concentration, the higher the 
value), if cells are absent, or if there are cells with a damaged 
membrane (the hemolysis condition). In addition, the phase shift 
of CPE2, ψ2, measures exactly one when cells are absent or their 
membrane is damaged (blood plasma and serum), indicating that, 
in such cases, CPE2 behaves like an ideal capacitor, with a very 
low capacitance C2.  
Interpolations of frequency points are shown in Figure 4, for 
all the blood components analyzed, in a real-imaginary plot, 
without double-layer compensation (the left panel) and with 
compensation (the right panel), which highlights the differences 
between the samples on the basis of their intrinsic characteristics. 
Imagining the natural extension of the compensated curves in 
Figure 4 towards infinite frequencies, it is evident that they tend 
to blood plasma in agreement with the decrease in the capacitive 
behavior at high frequencies. All the results confirm and verify 
the physical reasonability of the equivalent circuit that has been 
chosen and is proposed herein.  
 Single-frequency measurements 
With the aim of obtaining more accurate and informative 
results, measurements are generally expected to be performed 
using a multi-frequency approach. As previously described, the 
electrical impedance of blood components was measured over a 
Table 1. Extracted lumped elements according to the equivalent circuit. The values of C1, ψ1 represent the common double-layer effect, while the specific 
intrinsic blood components behavior can be described through the values of C2, ψ2 and R. 
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large frequency range, from 100 Hz to 2 MHz. Observing the 
signals of impedance magnitude (shown in Figure 3), we tried to 
identify the most ideal single frequency (among the frequencies 
used) in terms of accuracy and capability in discriminating the 
different blood components with resolution, with the purpose of 
improving the efficiency and performance of our measurements.  
Figure 5, which follows the same color codes used in Figure 
3, shows the quantitative analysis that is used for extracting the 
optimal frequency in the range [100 Hz, 2 MHz]. Observing the 
impedance magnitude signals in Figure 3, it is clear that the best 
frequency that is usable for a single-frequency measurement 
takes place in the central interval of frequencies, where the 
distance between signals seems to be greater than the distance at 
lower or higher frequencies. According to this observation, we 
quantified, for all the possible pairs of signals belonging to the 
adjacent blood components visible in Figure 3, the difference 
between their percentages in terms of impedance magnitude, 
choosing the worst difference for representation in Figure 5a the 
minimal distance between a blood component and its adjacent 
one. For example, to present the black line in Figure 5a, the 
percentage differences were computed between each red clot 
signal and each signal of whole blood concentrated, choosing, in 
the end, the lowest among the signals thus quantified. At the 
same time, we examined the trend of impedance magnitude 
standard deviation for each blood component, expressing it as a 
percentage of its average value and illustrating it in Figure 5b. 
According to the results shown in Figure 5a and Figure 5b, the 
optimal frequency is 104 Hz because, at this frequency, all the 
blood components can be accurately and completely 
discriminated (in terms of impedance magnitude) from the 
adjacent ones, as well as in the worst possible case. Figure 5c 
shows the discrimination of blood components at 104 Hz. 
 Impedance magnitude and hematocrit  
Hematocrit is the volume of red blood cells as a percentage 
of the whole blood volume, and its value can give information 
about the quality of blood transport and storage conditions. 
Hematocrit is a crucial parameter that is used to identify and 
quantity density variations or aggregative states in blood samples 
in situations of alteration that make blood unsuitable for analysis 
and unsuitable for transfusion. The hematocrit of each whole 
blood sample was measured with a commercial instrument that 
is commonly used in clinical laboratories and was compared with 
the impedance magnitude of the same sample, measured at 104 
Hz. As shown in Figure 6, by measuring the impedance with the 
proposed sensor, we are able to rapidly achieve the 
corresponding hematocrit value. In fact, the data appears highly 
correlated, with a Pearson’s correlation coefficient r = 0.89, and 
the correlation can be linearly approximated by y = 62.9 x + 6.8, 
where y represents the impedance magnitude and x represents 
 
Figure 4. Electrical impedance signals displayed as Real-Imaginary plot, without (left panel) and with (right panel) the compensation of the double layer 
effect. Each blood component is represented in terms of mean and standard deviation, both for the Real and the Imaginary part (n = 20). 
   
Figure 5. Optimal frequency quantification for single-frequency measurements. 
Worst percentage differences in impedance magnitude between adjacent 
blood components (a). Impedance magnitude standard deviation for each 
blood component, expressed as a percentage of the related average value (b). 
Impedance magnitude at 104 Hz, where each blood component is represented 
in terms of mean and standard deviation (n = 20).  
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the hematocrit values. The obtained results show that the 
proposed measuring system can be used to rapidly detect the 
blood hematocrit level. 
4. CONCLUSION 
Strategies in the field of risk management and patient safety 
are aimed at the prevention, detection, and reduction of adverse 
events by means of analysis of measurable and controllable 
errors. In clinical laboratories, the majority of critical issues occur 
in the pre-analytical phase, especially in activities in which the 
human component is still decisive. Information provided by 
clinical laboratories affects almost the totality of clinical decisions 
about diagnoses and treatments. Thus, the current focus of 
healthcare institutions is the improvement of patient safety, with 
more attention given to the prevention of pre-analytical mistakes 
and laboratory errors. The improvement of pre-analytical 
processes currently constitutes a challenge in clinical laboratories. 
The most frequently encountered problems are serum samples 
with hemolysis (in which their alteration is not visible and can 
compromise analytical results) and blood samples that are 
unsuitable for transfusion because of inappropriate sampling and 
storage conditions. There are different means and techniques 
available today, but the journey towards complete and effective 
rationalization of these laboratories is still long.  
In this work, we presented a new simple impedance-based 
biosensor to perform fast impedance measurements in the pre-
analytical phase. Different blood components were measured 
and characterized in terms of impedance magnitude and phase. 
In particular, observing the impedance magnitude signals of 
serum and whole blood, we identified the upper thresholds of 
700 Ω and 3 kΩ, respectively, as useful indicators for a fast check 
of the quality of the samples using our sensor. In addition, each 
blood component has been quantitatively described, estimating 
the parameters of the equivalent circuit proposed and finding 
some interesting and coherent correlations between the 
experimental results and the physical characteristics of the system 
investigated. All these results, together with the interpolation of 
the frequency points in the real-imaginary plot shown, have 
confirmed the adequacy of the equivalent circuit that has been 
chosen. The impedance analysis has also allowed for the 
quantitative identification of 104 Hz as the optimal frequency for 
performing single-frequency measurements with greater 
efficiency and without loss of accuracy. Finally, correlation 
between the impedance magnitude of the whole blood at 104 Hz 
and the hematocrit percentage value was achieved and 
quantified. Thanks to the impedance measurements and the 
electrical characterization of different components of blood 
samples, further optimization of costs, resources, and means of 
performing quality control (especially on serum and blood in the 
pre-analytical phase) has been proven as feasible. Through static 
electrical impedance measurements and analysis, it is possible to 
carry out very fast and automated controls for every sample, thus 
reducing the risk of errors in laboratory processes and limiting 
the propagation of these errors directly to the patients’ health and 
safety. 
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